Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News NICE Alzheimer’s drug ruling ‘a massive achievement’

NICE Alzheimer’s drug ruling ‘a massive achievement’

14th October 2010

A leading dementia charity has welcomed the National Institute for Health and Clinical Excellence's (NICE's) recent decision to expand access to Alzheimer's treatments.

Claire Bennett, press assistant at the Alzheimer's Society, said that NICE's preliminary decision to make four treatments for the condition available to early-stage patients is a "massive achievement".

The NICE ruling, which remains in the draft guidance stage, represents a u-turn on its previous stance, whereby only those with moderate or serious Alzheimer's symptoms could access the drugs.

Ms Bennett said this decision may lead to cost savings in future, as denying patients access to treatment is more likely to lead to them requiring 24-hour care.

She expressed hope that the new stance will now become official policy, which could have wider benefits due to NICE's influential status.

"NICE is well respected across Europe, so we're hoping it'll make a difference to people beyond England and Wales as well," said Ms Bennett.ADNFCR-8000103-ID-800116602-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.